2020
DOI: 10.1080/21623945.2020.1749500
|View full text |Cite
|
Sign up to set email alerts
|

Depot-specific adipocyte-extracellular matrix metabolic crosstalk in murine obesity

Abstract: 2020) Depot-specific adipocyteextracellular matrix metabolic crosstalk in murine obesity, Adipocyte, 9:1,[189][190][191][192][193][194][195][196], ABSTRACT Subcutaneous (SAT) and visceral (VAT) adipose tissues have distinct metabolic phenotypes. We hypothesized that the extracellular matrix (ECM) regulates depot-specific differences in adipocyte metabolic function in murine obesity. VAT and SAT preadipocytes from lean or obese mice were subject to adipogenic differentiation in standard 2D culture on plastic ti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
18
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(18 citation statements)
references
References 29 publications
0
18
0
Order By: Relevance
“…In humans, visceral adipose tissue is associated with insulin resistance, dyslipidaemia and Type 2 diabetes, while subcutaneous adipose tissue is associated with preserved insulin sensitivity and mitigates risk of metabolic disorders [30][31][32]. Moreover, in vitro study revealed that adipocytes from visceral adipose tissue rather than subcutaneous adipose tissue of obese mice showed impaired insulin-stimulated glucose uptake, adipogenesis ability and ECM remodelling representing dysfunctional adipocytes [33]. Thus, our result that Col24α1 mRNA expression was increased in the visceral adipose tissue of obese and diabetic subjects but not in the subcutaneous adipose tissue implied a potential pathogenic role of Col24α1 in obesity and Type 2 diabetes.…”
Section: Discussionmentioning
confidence: 99%
“…In humans, visceral adipose tissue is associated with insulin resistance, dyslipidaemia and Type 2 diabetes, while subcutaneous adipose tissue is associated with preserved insulin sensitivity and mitigates risk of metabolic disorders [30][31][32]. Moreover, in vitro study revealed that adipocytes from visceral adipose tissue rather than subcutaneous adipose tissue of obese mice showed impaired insulin-stimulated glucose uptake, adipogenesis ability and ECM remodelling representing dysfunctional adipocytes [33]. Thus, our result that Col24α1 mRNA expression was increased in the visceral adipose tissue of obese and diabetic subjects but not in the subcutaneous adipose tissue implied a potential pathogenic role of Col24α1 in obesity and Type 2 diabetes.…”
Section: Discussionmentioning
confidence: 99%
“… 3 Visceral adipose tissue in human is more closely associated with metabolic disease than subcutaneous adipose tissue. 4 The rate of obesity has almost tripled globally in the last decades, with an estimated 1.9 billion adults overweight. 5 Although obesity has become a pandemic and a major burden in one of the high-income countries in Kingdom of Saudi Arabia.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, high levels of LAMB1 were observed in visceral adipose tissue and during in vitro adipogenesis. Obesity alters the gene expression profile of ECM genes in adipose tissue (LAMB1 was upregulated in visceral and subcutaneous adipose tissue) [57][58][59][60]. The lactate dehydrogenase A protein (LDHA) catalyzes the conversion of pyruvate to lactate in the glycolytic metabolism.…”
mentioning
confidence: 99%